A data set was generated to examine global changes in gene expression in rat liver over time in response to a single bolus dose of methylprednisolone. Four control animals and 43 drug-treated animals were humanely killed at 16 different time points following drug administration. Total RNA preparations from the livers of these animals were hybridized to 47 individual Affymetrix RU34A gene chips, generating data for 8799 different probe sets for each chip. Data mining techniques that are applicable to gene array time series data sets in order to identify drug-regulated changes in gene expression were applied to this data set. A series of 4 sequentially applied filters were developed that were designed to eliminate probe sets that were not expressed in the tissue, were not regulated by the drug treatment, or did not meet defined quality control standards. These filters eliminated 7287 probe sets of the 8799 total (82%) from further consideration. Application of judiciously chosen filters is an effective tool for data mining of time series data sets. The remaining data can then be further analyzed by clustering and mathematical modeling techniques.
INTRODUCTION
Corticosteroids are widely used therapeutically to suppress inflammatory/immune responses. However, this class of drugs has a low therapeutic index owing to their extensive effects on many tissues. [1] [2] [3] [4] Corticosteroids produce most of their effects either by altering transcription of specific genes directly, or by indirectly altering the expression of transcription factors that subsequently alter the expression of downstream genes. Changes in the expression of genes in the liver are important to both the efficacious and the adverse effects of corticosteroids.
Microarrays can provide a method of high throughput data collection that is necessary for constructing comprehensive information on the transcriptional basis of polygenic phenomena. When microarrays are used in a rich in vivo time series, they yield temporal patterns of changes in gene expression that illustrate the cascade of molecular events that cause broad systemic responses. Mechanism-based pharmacokinetic/pharmacodynamic (PK/PD) models provide a tool for constructing testable hypotheses using these temporal patterns.
Previously we described the mining and cluster analysis of a microarray time series, illustrating the response of liver to the corticosteroid methylprednisolone (MPL). 5 This time series included individual chips from multiple control animals as well as multiple animals at each of 16 times over a 72-hour period following bolus dosing with MPL. Our first approach to analyzing this data set combined the processes of data mining and clustering and relied on 2 clustering methods, self-organizing maps (SOM) and K-means, followed by correlation coefficients between the probe sets in clusters. The result of that analysis was elaboration of 196 regulated probe sets coding for 143 individual genes. These probe sets were divided into 6 clusters of probe sets with similar temporal signatures. Mechanismbased PK/PD models were then developed for each of the 6 clusters. However, on further consideration of the data set using extensive pathway analysis, it became apparent that the initial analysis of this data set eliminated many biologically relevant regulated probe sets.
Mining a time series data set presents uniquely different problems from those encountered when microarrays are used to distinguish one group from another (eg, cancerous vs noncancerous tissues). [6] [7] [8] For those applications an attempt is made to define a pattern or fingerprint that distinguishes with very high probability one group from another and need not include all differentially regulated genes. In these cases, it is the distinguishing pattern of gene expression rather than the relationship between the genes that is the important focus. In the present application of microarrays, the problem is sorting through the vast amount of data to identify probe sets with temporal patterns of change in expression that indicate that the gene is regulated in response to the drug. In this case, the mechanistic relationships between the genes whose expression is changing in response to the drug are of paramount importance. For example, the drug may change the expression of a particular transcription factor that in turn alters the expression of downstream genes. For this application, the most important aspect of the initial data mining is to avoid discarding valuable data. This is of particular importance because each gene that is identified as being potentially regulated becomes the subject of extensive literature searches to allow placement into a temporal context of all other regulated genes. The purpose of the endeavor is to use PK/PD modeling to develop a ''motion picture'' of the polygenic response to the drug.
In the present report, we describe a new approach to analysis of this data set that focuses on the process of data mining (identifying regulated probes). We took advantage of the inherent redundancy of this rich time series, which contains many time points and multiple measurements per time point, to develop a sequence of filters that identified and removed probe sets that did not meet explicitly defined criteria. These filters eliminated more than 7000 of the 8799 probe sets from the data set. Using this procedure, the remaining 1512 probe sets can then become the focus of more intense scrutiny by other methods including temporal clustering, functional clustering, and PK/PD modeling, which provide additional ways of organizing and limiting the number of probes and genes of interest.
MATERIALS AND METHODS

Experimental Design
Liver samples were obtained from a previously performed animal study in our laboratory. 9 All procedures involving experimental animals adhered to the National Institutes of Health (NIH) principles of laboratory animal care and were reviewed by our institutionÕs institutional animal care and use committee (IACUC). Male adrenalectomized (ADX) Wistar rats (Rattus rattus) weighing 225 to 250 g were obtained from Harlan Sprague-Dawley (Indianapolis, IN). One day prior to the study, all rats were subjected to right external jugular vein cannulation under light ether anesthesia. Four animals were designated as controls (ie, zero time samples) and received vehicle only. All remaining animals received a single 50-mg/kg dose of MPL sodium succinate (Pharmacia-Upjohn Co, Kalamazoo, MI) via the cannula over 30 seconds. Three rats were killed by exsanguination under anesthesia at the following time points: 0.25, 0.5, 0.75, 1, 4, 5.5, 6, 7, 8, 18 , and 48 hours after dosing. Because of loss during the course of the experiment, only 2 rats were killed at 2, 5, 12, 30, and 72 hours after dosing. The sampling time points were selected based on previous studies describing glucocorticoid receptor (GR) dynamics and enzyme induction in liver and skeletal muscle. [9] [10] [11] The use of vehicle-treated animals as controls was based on extensive experimentation and PK/PD modeling by our laboratories. That work and attendant modeling demonstrated that, using this experimental construct and ADX animals, regulated mRNAs and protein deviate from a vehicle control-defined baseline and return to that baseline within a 72-hour period. 5 
Microarrays
Liver powder (100 mg) from each individual animal was added to 1 mL of prechilled Trizol reagent (Invitrogen, Carlsbad, CA), and total RNA extractions were performed according to manufacturerÕs directions. Extracted RNAs were further purified by passage through RNAeasy minicolumns (QIAGEN, Valencia, CA) according to manufacturerÕs protocols for RNA cleanup. Final RNA preparations were resuspended in RNase-free water and stored at -80°C. The RNAs were quantified spectrophotometrically, and purity and integrity were assessed by agarose gel electrophoresis.
Isolated RNA from each individual liver was used to prepare target according to manufacturerÕs protocols. The biotinylated cRNAs were hybridized to 47 individual Affymetrix GeneChips Rat Genome U34A (Affymetrix Inc, Santa Clara, CA), which contained 8799 probe sets. Unlike the cDNA arrays used in a previous study, 12 the high reproducibility of in situ synthesis of oligonucleotide chips allows accurate comparison of signals generated by samples hybridized to separate arrays. This entire data set has been submitted to the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus database (GSE490) and is also available online at www.pepr. cnmcresearch.org.
Data Analysis
The Affymetrix oligonucleotide microarrays use sequence information and photolithograpy-directed combinatorial chemical synthesis to develop probe sets for the genes of interest. Each probe set consisted of a series of short oligonucleotide sequences and an identical partner sequence, except for a single base mismatch in the center. The mismatch sequence provides a unique background for each sequence in the series. Affymetrix Microarray Suite 5.0 (Affymetrix) was used for initial data acquisition and basic analysis. In this first step, a ''call'' of present (P), absent (A), or marginal (M) was determined for each probe set on each chip based on the comparison of the matched and mismatched pairs for the gene sequence. The results were normalized for each chip using a distribution of all genes around the 50th percentile. The results from the first step were inputted to the program, GeneSpring 6.1 (Silicon Genetics, Redwood City, CA). 
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RESULTS
The approach to data mining was developed based on our use of gene arrays as a technique for high throughput data collection within the context of a rigidly controlled time series paradigm. The initial step in the data mining analysis was to transform the data so that the values for all probe sets were within the same range. To accomplish this, values for each individual probe set on each chip were expressed as a ratio to the mean of the 4 control values for that gene, which we refer to as ''normalized intensity.'' Thus, the average of each probe set has a value of 1 at zero time and either decreases, increases, or remains not different from controls over the time series. To monitor the progression of the mining, we used the gene tree tool developed by Eisen et al. 13 This algorithm can be used to construct a dendrogram of genes with similar patterns. A negative aspect of this tool, and most clustering algorithms when applied to time series data, is the assumption that the points in the time series are equally spaced. Notwithstanding this drawback, gene trees provide an excellent method of visualizing the progression of the data analysis. Figure 1 (top left) shows the gene tree derived from the GeneSpring program for the entire data set (8799 probe sets at 17 time points). The x-axis presents the 17 time points (including zero time controls) studied in rank order from left to right. Vehicle controls are nominally referred to as time zero. As indicated above, with this visualization tool each time point is equally spaced and therefore does not represent the actual temporal relationship between points. The y-axis presents the mean of the normalized value at each time point for each of the individual probe sets, represented by color and clustered by similarity. In this view, the color yellow represents a value of ''1''; progression toward red represents values that exceed ''1''; and progression toward blue represents values that decline toward zero. The intensity of the color reflects the intensity of the original signal. To the left of the figure is a schematic tree of the relationship of all probe sets to each other based on expression pattern similarity (represented in green). On the left side of the figure, but spatially separated, is what is referred to as a ''marquee view'' in the GeneSpring software. This marquee view can be used to 
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navigate the view of the tree on the right. Although the gene tree representation of the entire data set is of limited value for examining individual gene patterns of regulation, it does illustrate 2 points. First, within the entire data set are a vast number of genes represented by black (no expression in liver regardless of treatment) or by the color yellow across the entire time frame studied. This latter group of genes exhibits no temporal regulation by the drug (ie, their expression does not deviate from control value following drug dosing) and represents probe sets that we wish to filter from the data set. Second, it does reflect segregation of similarly regulated genes and demonstrates that similar patterns of regulation do exist. For example, groups of intense red or blue represent clusters of genes with similar up-or down-regulation respectively. Figure 1 (top right) provides a zoom-in view of one such clustering of probe sets with apparent down-regulation. The location of this group of probe sets within the entire data set is indicated by brackets. Figure 1 (bottom) shows an even closer zoom-in on 3 probe sets in this grouping with similar patterns. All 3 of these probe sets are for glutamate cysteine ligase, which is involved in cysteine metabolism and glutathione biosynthesis. The fact that these down-regulated probe sets reside together on the gene tree illustrates both the high Figure 2 . Gene tree of the 4373 probe sets remaining after filtering to remove probe sets not expressed in liver regardless of drug treatment, as described in the text. The gene tree is as described in Figure 1 .
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reproducibility of the Affymetrix gene chips and the ideal functioning of the Eisen et al approach to grouping genes. 13 A series of ''filtering'' steps were applied to the data in an attempt to eliminate probe sets that were not of further interest. The first level of filtering was designed to eliminate probe sets not expressed in liver, and used the Affymetrix ''call'' feature. This first filter required that the probe set for the gene have a call of P on at least 4 of the 47 chips. This filter eliminated 4426 probe sets from the data set. Figure 2 provides a gene tree of the 4373 probe sets not eliminated by this first filter. The gene tree also demonstrates that as probe sets are eliminated there is a more intense concentration of probe sets with contiguous strings of red and blue.
The second level of filtering that we applied was designed to eliminate probe sets that could not meet the basic criterion of a regulated probe. Specifically, this filter was designed to eliminate probe sets whose average did not deviate from baseline by a certain value for a reasonable number of time points. After exploring a variety of filtering values and number of conditions using gene trees in the manner described in the previous paragraph, we developed 2 filters that were designed to eliminate probe sets that were neither down-nor up-regulated. The first of these filters eliminated probe sets that could not meet a minimal criterion for down-regulation. Starting with the 4P filtered list, we eliminated all probe sets that did not have average values below 0.65 in at least 4 conditions (time points). Figure 3 (left) shows a gene tree of the 829 probe sets that were not eliminated by this filter. Most of these probe sets clearly contain a sustained run of time points represented by the color blue, as expected of downregulated probe sets. The next filter was designed to eliminate probe sets that could not meet a minimal criterion for up-regulation. Starting with the 4P filtered list, we eliminated all probe sets that did not have average values above 1.5 in at least 4 conditions (time points). Figure 3 (right) shows a gene tree of the 817 probe sets that were not eliminated by this filter. Most of these probe sets clearly contain a sustained run of red time points as expected of up-regulated probe sets. There were a small number of probe sets that were not eliminated by either filter indicating both up-and down-regulation. These probe sets suggest biphasic regulation, a phenomenon we have previously described. 5 Thus, using 3 straightforward filters we were able to eliminate all but 18% of the probe sets present in the original data set.
The last filter we applied addressed the quality of the data. For this quality control filter we eliminated probe sets that 
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did not meet 2 conditions. The first condition focused on the control chips. As indicated above, our initial operation was to divide the value of each individual probe set on each chip by the mean of the values for that probe set on the 4 control chips. Therefore, the quality of the control data for each particular probe set is of unique importance in defining regulation by the drug. This filter eliminated probe sets whose control values exhibited coefficients of variation (CV) of greater than 50%. The second condition focused on the remaining 16 time points. This filter also eliminated probe sets that had CVs for more than 8 of the remaining 16 time points exceeding 50%. For the 11 points for which we had 3 samples, the CV was calculated using the SD of the mean. For the 5 points for which we only had 2 samples, a quasi-CV was calculated using the difference between the 2 values divided by the average. This quality control filter eliminated an additional 103 probe sets. Figure 4 (left) provides a gene tree of the 1512 probe sets that were not eliminated by the entire series of filters. Figure 4 (right) shows the 7287 probe sets that were filtered out by the entire set of filters. Comparing Figure 1 (top left) with Figure 4 (right) demonstrates that probes with apparent regulation are no longer present in the eliminated data set. The single exception to this observation is a small group of intensely blue probe sets at the bottom of the figure. Although they all were eliminated by the last filter owing to highly variable data, they do warrant noting. For all of these probe sets, the normalized value dropped from 1 in the controls to virtually zero and remained at zero throughout most of the time course. One of these probes, metallothionein, was one of the most highly expressed and up-regulated genes observed in an earlier gene array experiment on MPL-treated liver using a spotted array. 12 In discussions with Affymetrix, we learned that very intense signals can desensitize the photomultiplier tube (PMT) and yield a value of zero. Because of this limitation in the Affymetrix technology, some regulated probe sets cannot be captured in our studies and are eliminated from further analysis. The 1512 probe sets remaining after filtering the total data set (Figure 4 left) are the product of this approach to data mining and thus become the focus of temporal clustering, functional clustering, and PK/PD modeling.
A previous very stringent analysis of this data set, which combined data mining with clustering, yielded only 197 regulated probe sets. 5 Those probe sets are a subset of those identified here. However, that analysis demonstrated that variations on 3 basic temporal signatures of regulation can be expected following single bolus dosing by MPL of a population of ADX rats that have a stable baseline. These 3 signatures indicate up-regulation, down-regulation, and biphasic regulation. Figure 5 (top left, 738 probe sets; top right, 739 probe sets; and bottom, 23 probe sets) provides gene trees for probe sets that fall into these 3 categories. Tables 1, 2 , and 3 list the corresponding probe sets. 
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The purpose of developing this data set was to generate data that can be used to model the cascade of transcriptional events initiated in liver by MPL. Figure 6 (left) presents plasma MPL concentrations in these same animals, along with liver receptor densities (right). Figure 7 shows the parent model that uses kinetics as the driving force for the formation of the drug receptor complex (DR), which is translocated into the nucleus to become DR(N), which is the driving force for transcriptional changes. Models for the 3 general signatures are also provided in this figure. These models were derived from our initial analysis of this data set. 5 The first model is for direct stimulation of transcription, which is typified by the response of the acute phase protein a 2 -macroglobulin. The second model is for direct inhibition of transcription, which is typified by dihydropyrimidinase. The last model is for a biphasic regulation of transcription. This model is for arginase, whose mRNA first declines and later is enhanced. The biphasic nature of the curve suggests that 2 mechanistic processes are involved. This model describes the initial decline as DR stimulating the degradation of the mRNA and the later increase as DR(N) stimulating the synthesis of a biosignal (BS) that, following translation into protein, stimulates the production of mRNA. There is strong evidence that in this case the BS is CCAAT-enhancer binding protein beta (CEBPb), whose expression is enhanced by MPL. 14 Figure 8A shows the fitting of 4 probe sets for a 2 -macroglobulin using the direct stimulation model. Figure 8B shows the fitting of 2 probe sets for dihydropyrimidinase using the direct inhibition model. Figure 8C shows the fitting of a probe set for arginase using the biphasic model.
DISCUSSION
A population of ADX male Wistar rats was injected with a single bolus dose of MPL; groups of animals were killed at 16 time points over a 72-hour period; and MPL-treated liver samples were compared with vehicle-treated controls. ADX animals were used to eliminate the circadian oscillation of corticosterone and provide a stable baseline. [9] [10] [11] [15] [16] [17] This allowed us to identify gene transcripts that deviate from the baseline in response to MPL and determine the duration of time it takes to return to that baseline. The times of killing over the 72-hour period were chosen based on previous experiments indicating that the effect of the drug was most significant at the early times following dosing, but full recovery required in some cases as long as 72 hours. Dri 27/ZnT4 protein L25605_at dynamin 2
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Affymetrix RU34A chips were used to examine the temporal profile of changes in global gene expression in liver in response to this single bolus dose of MPL. RNA samples from each individual animal were applied to a separate chip to preserve interanimal variation. Because this chip contains 8799 probe sets, the major problem was identifying the relatively small percentage of the probe sets that are regulated by corticosteroids. In a previous study, we used cluster analysis tools and correlation coefficients to concurrently address the problems of data mining and temporal clustering with this data set. 5 Those tools did identify 6 clusters of regulated probe sets with different temporal signatures. However, while examining genes in pathways we were prompted to visually inspect the results for genes that ''should'' have been regulated based on the literature. The results of the visual inspection of individual genes demonstrated to us that the initial very stringent approach that we employed eliminated probe sets that were clearly regulated. There are 2 reasons for this deficit. First, we approached data mining (identifying regulated probe sets) and clustering (grouping probe sets with simi- Probe Set ID Gene Name
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E189 lar temporal signatures) as a single process. Second, we applied clustering algorithms based on Euclidian distance and correlation coefficients. Neither Euclidian distance nor correlation coefficients incorporate time interval, in that they treat all time domains as equal in magnitude. In our time series design, 9 of the 16 points are within the first 6 hours, and 12 of the 16 points are within the first 12 hours following drug dosing. The interval between time domains ranged from 0.25 hours in the beginning to 24 hours at the end. The assumption that these time domains are equal greatly impairs the effectiveness of most current mathematical tools for mining and clustering biologically relevant time series data.
We therefore developed a new approach to data mining that is based on a series of filters designed to eliminate probe sets that do not meet certain explicit criteria. This series of filters produces a remainder of a relatively small percentage of the total probe sets that then can become the focus of temporal and functional clustering. For example, we have identified in the data set probe sets for a group of more than 20 genes involved in nitrogen disposal in the liver. These probe sets reflect several different temporal signatures but constitute a functional cluster that can be used for PK/PD modeling. Two of the genes in this functional cluster are C/EBPd and arginase 1 discussed above.
Other functional clusters identified in the data set relate to lipid metabolism, gluconeogenesis, and immunosuppression. Such functional clustering based on text mining of the literature will provide an additional filtering process prior to the application of mechanism-based PK/PD modeling. Since we have previously published data on expression changes of small groups of genes measured individually by other methods in conjunction with PK/PD modeling of that data, the drug kinetics and receptor dynamics for this data set have been published. 9 The foundation of this new approach is filtering the data based on specific characteristics of the probe sets to be eliminated. The first filter we applied was designed to eliminate all probe sets that were not expressed in the liver. This filter reduced the number of probe sets under consideration from 8799 to 4373. The second filter we applied was designed to identify and eliminate a group of probe sets that do not meet the minimal criteria of down-regulation. This filter eliminated all but 829 probe sets. Similarly, we filtered for those that did not meet the minimal criteria for up-regulation. This filter eliminated all but 817 probe sets. We then combined the 2 lists of probe sets that had not been eliminated and filtered that list of 1615 probe sets on data quality. The results of the entire set of filters is that 7287 probe sets of the original 8799 probe sets were eliminated from further consideration. This left a remainder of 1512 probe sets for further consideration with respect to temporal clustering, functional clustering, and PK/PD modeling.
In a previous report 5 in which we handled data mining and clustering as a single screening process we separated these liver probe sets into six clusters. Probe sets in the six clusters were identified by correlation with exemplars. Two of those clusters (4 and 6) were designated as biphasic with differing but strongly evident temporal patterns and were used for modeling purposes. Cluster 4 contained 66 probe sets and cluster 6 contained 68 probe sets. Twenty-seven of the 134 probe sets in those clusters failed the present quality control filter and are not included in this report. We presently have placed only 27 probe sets in the biphasic group. As detailed above, these probe sets were sequestered in this group because they passed both the filter of 0.65 in four conditions and the 1.5 filter in four conditions. The remaining probes in the previously described clusters 4 and 6 only passed one of these two filters and are 
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contained in either the up-or down-regulated tables. This may be due to too few data points beyond 12 hours. These differences in resolution of patterns are indicative of the difficult problem of finding both computationally and biologically meaningful approaches to clustering of gene array profiles.
CONCLUSION
The use of a rich time series and microarrays as a high throughput method of data collection provides a means for obtaining the mRNA expression profiles necessary for developing PK/PD models for complex polygenic phenomena such as nitrogen, carbohydrate, and lipid metabolism. Figure 7 . The proposed general model for corticosteroid-induced pharmacogenomic effects, and 3 specific models describing direct stimulation of transcription, direct inhibition of transcription, and biphasic regulation. DR indicates drug-receptor complex in cytosol; DR(N), drug-receptor complex in nucleus; mRNA, target mRNA level; k s_m , zero-order rate of the target mRNA synthesis; k d_m , first-order rate of the target mRNA degradation; S, linear stimulation factor; mRNA 0 , baseline mRNA level; mRNA BS , the message level of the intermediate regulator BS (normalized as ratio to 0-hour control); BS r , the protein level of the BS (normalized); k T , first-order rate of the drug-receptor complex translocation into the nucleus; k s_BSm , zero-order rate of BS mRNA synthesis; k d_BSm , first-order rate of BS mRNA degradation; k s_BS , first-order rate of BS translation to protein; k d_BS , first-order rate of BS protein degradation; S BSm 
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The initial problem presented by this approach is to focus attention on a small percentage of regulated genes out of the thousands measured by gene arrays. Probes that fit this category should meet minimal requirements such as being expressed in the tissue and deviating from baseline for a period of time. They should also meet certain data quality criteria. The series of filters applied to the present data set eliminated more than 82% of the probe sets in a simple, straightforward manner. It should be pointed out that this filtration approach takes advantage of the richness of the time series design. Since this entire data set is available online in a single gene query format, 18 the present report makes generally available the subset of probe sets that warrant further consideration along with their criteria of selection.
